These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 19497202)

  • 1. [Hepatitis B virus P22(e) inhibit hepatocyte apoptosis via nuclear factor kappa B].
    DIAO ZH; ZHANG MX; ZHU YF; SHI YL; HOU JL
    Zhonghua Gan Zang Bing Za Zhi; 2009 May; 17(5):359-62. PubMed ID: 19497202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hepatitis B virus P22e protein inhibits human hepatocellular carcinoma HepG2 cell apoptosis in vitro].
    Diao ZH; Zhang MX; Zhu YF; Hou JL
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Nov; 27(11):1649-52. PubMed ID: 18024281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of NF-kappa B pathway on apoptosis of hepatic carcinoma cell line-7721 induced by TNF-alpha].
    Yang JY; Zeng XY; Ma BR
    Ai Zheng; 2002 Sep; 21(9):974-8. PubMed ID: 12508545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The influence of HBV/P22 protein on the apoptosis of HepG2 cells: an experimental study].
    Zhang F; Diao ZH; Yu ZJ; Zhang MX; Zhu YF
    Zhonghua Gan Zang Bing Za Zhi; 2008 Jan; 16(1):21-4. PubMed ID: 18226338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of nuclear factor kappaB in hepatitis C virus infection: implications for pathogenesis and hepatocarcinogenesis.
    Tai DI; Tsai SL; Chen YM; Chuang YL; Peng CY; Sheen IS; Yeh CT; Chang KS; Huang SN; Kuo GC; Liaw YF
    Hepatology; 2000 Mar; 31(3):656-64. PubMed ID: 10706556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive activation of nuclear factor kappaB in hepatocellular carcinoma.
    Tai DI; Tsai SL; Chang YH; Huang SN; Chen TC; Chang KS; Liaw YF
    Cancer; 2000 Dec; 89(11):2274-81. PubMed ID: 11147598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Rel/NF-kappaB transcription factors in apoptosis of human hepatocellular carcinoma cells.
    Chiao PJ; Na R; Niu J; Sclabas GM; Dong Q; Curley SA
    Cancer; 2002 Oct; 95(8):1696-705. PubMed ID: 12365017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced nuclear factor-kappa B-associated Wnt-1 expression in hepatitis B- and C-related hepatocarcinogenesis: identification by functional proteomics.
    Lee TH; Tai DI; Cheng CJ; Sun CS; Lin CY; Sheu MJ; Lee WP; Peng CY; Wang AH; Tsai SL
    J Biomed Sci; 2006 Jan; 13(1):27-39. PubMed ID: 16228287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B Virus Precore Protein p22 Inhibits Alpha Interferon Signaling by Blocking STAT Nuclear Translocation.
    Mitra B; Wang J; Kim ES; Mao R; Dong M; Liu Y; Zhang J; Guo H
    J Virol; 2019 Jul; 93(13):. PubMed ID: 31019054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Subcellular distribution and translocation of hepatitis B virus core protein in HepG2.2.15 cells].
    Pan XB; Han JC; Wei L; Peng DD; Gao Y
    Zhonghua Gan Zang Bing Za Zhi; 2008 Jan; 16(1):29-32. PubMed ID: 18226340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caspase-mediated p65 cleavage promotes TRAIL-induced apoptosis.
    Kim HS; Chang I; Kim JY; Choi KH; Lee MS
    Cancer Res; 2005 Jul; 65(14):6111-9. PubMed ID: 16024612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoplasmic localization is important for transcription factor nuclear factor-kappa B activation by hepatitis C virus core protein through its amino terminal region.
    Watashi K; Hijikata M; Marusawa H; Doi T; Shimotohno K
    Virology; 2001 Aug; 286(2):391-402. PubMed ID: 11485407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of the hepatitis B virus X fragment in hepatocellular carcinoma and its effects on the expression of multiple molecules: a key to the cell cycle and apoptosis.
    Peng Z; Zhang Y; Gu W; Wang Z; Li D; Zhang F; Qiu G; Xie K
    Int J Oncol; 2005 Feb; 26(2):467-73. PubMed ID: 15645132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of myocardial apoptosis by postconditioning is associated with attenuation of oxidative stress-mediated nuclear factor-kappa B translocation and TNF alpha release.
    Kin H; Wang NP; Mykytenko J; Reeves J; Deneve J; Jiang R; Zatta AJ; Guyton RA; Vinten-Johansen J; Zhao ZQ
    Shock; 2008 Jun; 29(6):761-8. PubMed ID: 18496137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of siRNA-mediated inhibition of nuclear transcription factor-kappa B on apoptosis of hepatocarcinoma cells].
    Wang YL; Yao DF; Wu W; Sai WL; Qiu LW; Yang JL; Zhu JW
    Zhonghua Gan Zang Bing Za Zhi; 2010 Aug; 18(8):609-13. PubMed ID: 20825717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fas/Apo-1 activates nuclear factor kappa B and induces interleukin-6 production.
    Rensing-Ehl A; Hess S; Ziegler-Heitbrock HW; Riethmüller G; Engelmann H
    J Inflamm; 1995; 45(3):161-74. PubMed ID: 8597871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of NF-kappaB in Hepatitis b virus X protein-mediated upregulation of VEGF and MMPs.
    Liu LP; Liang HF; Chen XP; Zhang WG; Yang SL; Xu T; Ren L
    Cancer Invest; 2010 Jun; 28(5):443-51. PubMed ID: 20073580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.
    Chen X; Kandasamy K; Srivastava RK
    Cancer Res; 2003 Mar; 63(5):1059-66. PubMed ID: 12615723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of nuclear factor-kappaB, urokinase-type plasminogen activator, and HBx and their clinicopathological significance in hepatocellular carcinoma.
    Chan CF; Yau TO; Jin DY; Wong CM; Fan ST; Ng IO
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4140-9. PubMed ID: 15217951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DHMEQ, a novel NF-kappaB inhibitor, induces apoptosis and cell-cycle arrest in human hepatoma cells.
    Nishimura D; Ishikawa H; Matsumoto K; Shibata H; Motoyoshi Y; Fukuta M; Kawashimo H; Goto T; Taura N; Ichikawa T; Hamasaki K; Nakao K; Umezawa K; Eguchi K
    Int J Oncol; 2006 Sep; 29(3):713-9. PubMed ID: 16865289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.